A novel mouse model of cerebral microbleeds by targeted Col4a1 editing in adult brain microvessels
Brain · 2026
DOI: 10.1093/brain/awag048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Hyunmi Kim und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain Science, Ajou University School of Medicine, Suwon 16499, Republic of Korea. Hauptthemen laut MEDLINE: Collagen Type IV, Cerebral Hemorrhage, Microvessels, Disease Models, Animal. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea (NRF) research programs, Korea Initiative for fostering University of Research and Innovation (KIURI) Program of the National Research Foundation (NRF) funded by the Korean government, Ajou University Medical Center.
Abstract (Originalsprache)
Cerebral small vessel disease is a leading cause of cognitive decline and stroke in the elderly, with cerebral microbleeds (CMBs) serving as a key imaging biomarker. Despite their clinical significance, the pathophysiological mechanisms underlying cerebral small vessel disease remain poorly understood owing to a lack of appropriate animal models. We performed targeted deletion of Col4a1 in brain microvessels of adult mice using brain endothelium-specific adeno-associated virus (AAV)-BR1 vectors with clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9). Eight-week-old Cas9 transgenic mice received retro-orbital injections of AAV-BR1 containing single guide RNA (sgRNA) targeting Col4a1 or control Rosa26 sequences. Animals underwent longitudinal behavioural testing, including novel object recognition, Y-maze and rotarod tests, over 6 months. Brain pathology was assessed using T2*-weighted MRI, histological analysis and electron microscopy. For human studies, we analysed MRI and genomic data from 836 participants from the BICWALZS biobank, examining associations between genetic variants and CMB burden using linear regression and χ2 analyses. T2*-weighted MRI revealed numerous CMBs with distributions remarkably similar to human CMBs, appearing within 3 months post-injection. CMB burden increased progressively over 6 months in a dose-dependent manner. Behaviourally, mice exhibited progressive cognitive decline and motor incoordination. Histological examinations revealed haemosiderin deposits corresponding to MRI-detected CMBs, without macroscopic intracerebral haemorrhage or white matter changes. Ultrastructural analysis demonstrated significant basement membrane thinning in Col4a1-depleted microvessels. CMB accumulation was associated with widespread astrocytic reactivity extending beyond microbleed sites, whereas microglial activation remained localized. In human subjects, we identified significant associations between four genetic variants of TIMP2, an endogenous inhibitor of the matrix-degrading enzyme MMP2 and CMB burden, with odds ratios of 1.50–1.96 for increased microbleed susceptibility. This work provides the first animal model demonstrating that selective disruption of collagen IV in adult brain microvessels is sufficient to generate CMBs with high penetrance and dose-dependent tunability. Our findings establish that basement membrane integrity is critical for preventing microbleed formation and suggest that dysregulated collagen IV homeostasis underlies sporadic human CMB development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Brain Science, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
- AI-Superconvergence KIURI Translational Research Center, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
- R&D Center, ToolGen Inc., Seoul 06591, Republic of Korea.
- Department of Anatomy, Catholic Neuroscience Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Medical Sciences, Graduate School, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Neurology, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
ORCID-Profile: Sang Joon Son, Byung Gon Kim
Förderung
- National Research Foundation of Korea (NRF) research programs
- Korea Initiative for fostering University of Research and Innovation (KIURI) Program of the National Research Foundation (NRF) funded by the Korean government
- Ajou University Medical Center
- National Institute of Health (NIH)
Zitieren
APA
Kim, H., Seo, Y., Kho, H., Singh, S. S., Lee, J., Lee, H., Hwang, J. W., Riew, T. R., Koh, S., Choi, J. Y., Roh, H. W., Son, S. J., Kim, G. T., Cho, S. K., Jin, H. S., Jeong, S. Y., Lee, K. I., Lee, J. Y., & Kim, B. G. (2026). A novel mouse model of cerebral microbleeds by targeted Col4a1 editing in adult brain microvessels. Brain. https://doi.org/10.1093/brain/awag048
Vancouver
Kim H, Seo Y, Kho H, Singh SS, Lee J, Lee H, et al. A novel mouse model of cerebral microbleeds by targeted Col4a1 editing in adult brain microvessels. Brain. 2026. doi:10.1093/brain/awag048
BibTeX
@article{Kim2026,
author = {Kim, Hyunmi and Seo, Yeojin and Kho, Heekyung and Singh, Shivani Shailendrakumar and Lee, Jina and Lee, Hohyeon and Hwang, Ji-Won and Riew, Tae-Ryong and Koh, Seungyon and Choi, Jun Young and Roh, Hyun Woong and Son, Sang Joon and Kim, Gi Tae and Cho, Sung Kweon and Jin, Hyun-Seok and Jeong, Seon-Yong and Lee, Kang In and Lee, Jae Young and Kim, Byung Gon},
title = {A novel mouse model of cerebral microbleeds by targeted Col4a1 editing in adult brain microvessels},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag048}
}
EUVIMED